Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : 2026 TeoTwawKi ... 2032 Darkest Interregnum -- Ignore unavailable to you. Want to Upgrade?

To: TobagoJack who wrote (155832)	4/3/2020 9:12:37 AM
From: ggersh	1 Recommendation Recommended By marcher Read Replies (1) \| Respond to of 217764

bullionstar.com

To: TobagoJack who wrote (155832)	4/3/2020 1:46:53 PM
From: carranza2	1 Recommendation Recommended By SirWalterRalegh Read Replies (4) \| Respond to of 217764

There’s going to be an enormous up day when hydrochloroquine is approved for treatment, though it should’ve been approved long ago. Think of the implications: less time on ventilators, less stress on health care, a demand that lock downs cease, that economic activity resume. Pent up demand will drive economic numbers in a very positive way. That day will come without warning. Shorts will be slaughtered for at least a day or two. The second part of the hydrochloroquine experience will be when it is approved for prophylactic purposes, which I believe is very likely. All the crazy protective measures will be unnecessary. In the meantime, other therapies, etc., will come up. The V shaped recovery makes sense to me, stock market to follow because the re-arranging of economic activity created by the virus will create enormous opportunities.